New drug FL115 tested in advanced cancer patients
Disease control
Ongoing
This early-phase study tests a new drug called FL115 in 30 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants receive FL115 alone, and the st…
Phase: PHASE1 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated May 17, 2026 13:54 UTC